Filter by Type

Drug Status

Node Types

Sleep Disorder
Comorbid Condition
FDA Approved Drug
Pipeline Drug
Pharma Company
Priority Review

Connections

Drug → Disorder
Comorbidity (dashed)

Line Thickness

= Comorbidity strength of association
Medical Universe (background)

⚡ Narcolepsy: Massively Underdiagnosed

Est. 200,000 Americans affected, but ~75% undiagnosed (~150,000 patients). Avg diagnosis delay: 8-15 years.

🔴 Takeda's oveporexton (TAK-861) — FDA Priority Review for NT1. PDUFA: Q3 2026. First-in-class OX2R agonist.

Medical Universe: 1,375 conditions · 25,414 connections
Drag to rotate · Scroll to zoom · Click node to focus · Right-drag to pan